Subtopic Deep Dive
Hodgkin Lymphoma PET Imaging
Research Guide
What is Hodgkin Lymphoma PET Imaging?
Hodgkin Lymphoma PET Imaging uses FDG-PET/CT for initial staging, interim response assessment, and end-of-treatment evaluation in Hodgkin lymphoma according to Lugano criteria and Deauville scoring.
FDG-PET/CT replaced CT for accurate staging and response assessment in Hodgkin lymphoma, as standardized by the Lugano Classification (Cheson et al., 2014, 5254 citations). Interim PET guides therapy de-escalation using Deauville scores 1-3 for reduced intensity (Barrington et al., 2014, 1589 citations). Over 10,000 papers reference these consensus guidelines for clinical trials and practice.
Why It Matters
PET-directed therapy in Hodgkin lymphoma reduces treatment toxicity while preserving 90%+ cure rates in early-stage disease (Engert et al., 2010, 904 citations). Interim PET negative patients achieve 85-90% progression-free survival without radiotherapy (Radford et al., 2015, 732 citations). Response-adapted ABVD omission of bleomycin cuts pulmonary toxicity by 10% (Johnson et al., 2016, 773 citations). These strategies lower long-term risks like secondary cancers in young patients.
Key Research Challenges
Interim PET False Positives
Inflammation causes Deauville 4 scores mimicking residual disease, leading to overtreatment (Juweid et al., 2007, 1330 citations). Quantitative metrics like SUVmax thresholds improve specificity but lack standardization (Barrington et al., 2014). Trials show 10-15% false positive rate affects de-escalation decisions.
End-of-Treatment Overstaging
Persistent FDG uptake post-therapy exceeds liver SUV, prompting unnecessary salvage despite cure (Cheson et al., 2014). Lugano criteria require 3-month delayed scans for accuracy. This delays consolidation and increases anxiety in 20% of complete responders.
Quantitative PET Metrics
Deauville score relies on visual interpretation with inter-reader variability up to 20% (Meignan et al. in Barrington et al., 2014). Metabolic tumor volume and total lesion glycolysis predict relapse better but need validation across scanners (Juweid et al., 2007). Harmonization protocols remain inconsistent.
Essential Papers
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington et al. · 2014 · Journal of Clinical Oncology · 5.3K citations
The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). A workshop was held...
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · 2007 · Journal of Clinical Oncology · 4.4K citations
Purpose Standardized response criteria are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Methods The International Working Group...
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos et al. · 2022 · Leukemia · 3.3K citations
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu et al. · 2014 · Journal of Clinical Oncology · 1.6K citations
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling techniques have the potential to improve disease characterization and outcomes in lymphoma. International tria...
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
Malik E. Juweid, Sigrid Stroobants, Otto S. Hoekstra et al. · 2007 · Journal of Clinical Oncology · 1.3K citations
Purpose To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinical...
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Andreas Engert, Annette Plütschow, Hans Theodor Eich et al. · 2010 · New England Journal of Medicine · 904 citations
In patients with early-stage Hodgkin's lymphoma and a favorable prognosis, treatment with two cycles of ABVD followed by 20 Gy of involved-field radiation therapy is as effective as, and less toxic...
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hervé Tilly, María Gomes da Silva, Umberto Vitolo et al. · 2015 · Annals of Oncology · 893 citations
Reading Guide
Foundational Papers
Start with Lugano Classification (Cheson et al., 2014) for criteria standards; then PET Harmonization (Juweid et al., 2007) for FDG protocols; Engert et al. (2010) for early-stage de-escalation evidence.
Recent Advances
Johnson et al. (2016) for interim PET-guided ABVD adaptation; Radford et al. (2015) for PET-directed radiotherapy omission trials.
Core Methods
FDG-PET/CT acquisition at 60min post-injection; Deauville 1-3 negative for de-escalation; visual + SUV liver+40% threshold (Cheson et al., 2014; Barrington et al., 2014).
How PapersFlow Helps You Research Hodgkin Lymphoma PET Imaging
Discover & Search
Research Agent uses searchPapers('Hodgkin lymphoma interim PET Deauville') to retrieve Lugano Classification (Cheson et al., 2014), then citationGraph reveals 5000+ citing papers on response-adapted therapy, and findSimilarPapers identifies Engert et al. (2010) for de-escalation trials.
Analyze & Verify
Analysis Agent applies readPaperContent on Cheson et al. (2014) to extract Deauville criteria tables, verifyResponse with CoVe cross-checks interim PET NPV at 94% against Johnson et al. (2016), and runPythonAnalysis computes SUV thresholds from extracted data using pandas for meta-analysis, graded A by GRADE for high-quality evidence.
Synthesize & Write
Synthesis Agent detects gaps in quantitative PET standardization post-Lugano via contradiction flagging between visual vs. SUV criteria, while Writing Agent uses latexEditText for response criteria tables, latexSyncCitations for 10 Lugano papers, and latexCompile to generate a review manuscript with exportMermaid flowcharts of PET-adapted protocols.
Use Cases
"Extract SUV data from Hodgkin PET trials and compute pooled Deauville 4 sensitivity"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Cheson 2014, Johnson 2016) → runPythonAnalysis (pandas meta-analysis, matplotlib ROC curve) → CSV export of pooled 92% sensitivity for relapse prediction.
"Write LaTeX review of PET de-escalation in early Hodgkin lymphoma"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Lugano/Engert papers) → latexCompile → PDF with Deauville flowchart via exportMermaid.
"Find code for Hodgkin PET tumor volume segmentation"
Research Agent → paperExtractUrls (Barrington 2014) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (test MONAI segmentation on sample PET DICOMs) → validated PyTorch script for MTV calculation.
Automated Workflows
Deep Research workflow scans 50+ Lugano-citing papers via searchPapers → citationGraph → structured report on PET NPV trends 2007-2022. DeepScan's 7-step chain verifies interim PET protocols: readPaperContent → CoVe → GRADE → Python SUV pooling. Theorizer generates hypotheses on AI-Deauville scoring from Juweid/Barrington contradictions.
Frequently Asked Questions
What is the definition of Hodgkin Lymphoma PET Imaging?
FDG-PET/CT for staging, interim, and end-of-treatment assessment using Lugano criteria and 5-point Deauville score (Cheson et al., 2014).
What are the main methods in Hodgkin Lymphoma PET Imaging?
Visual Deauville scoring (1-5) compares lesion uptake to liver/mediastinum; quantitative SUVmax > liver+40% indicates positivity (Juweid et al., 2007; Barrington et al., 2014).
What are the key papers?
Lugano Classification (Cheson et al., 2014, 5254 citations); Imaging Consensus (Barrington et al., 2014, 1589 citations); PET Harmonization (Juweid et al., 2007, 1330 citations).
What are the open problems?
Reducing Deauville inter-reader variability; validating total lesion glycolysis for relapse prediction; scanner harmonization for multicenter trials (Barrington et al., 2014).
Research Lymphoma Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hodgkin Lymphoma PET Imaging with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Lymphoma Diagnosis and Treatment Research Guide